ATE238552T1 - Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen - Google Patents

Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen

Info

Publication number
ATE238552T1
ATE238552T1 AT97903154T AT97903154T ATE238552T1 AT E238552 T1 ATE238552 T1 AT E238552T1 AT 97903154 T AT97903154 T AT 97903154T AT 97903154 T AT97903154 T AT 97903154T AT E238552 T1 ATE238552 T1 AT E238552T1
Authority
AT
Austria
Prior art keywords
influenza virus
compounds usable
detecting influenza
usable therefor
compounds
Prior art date
Application number
AT97903154T
Other languages
German (de)
English (en)
Inventor
Philip A Reece
Wen-Yang Wu
Betty Jin
Guy Y Krippner
Keith Geoffrey Watson
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN8397A external-priority patent/AUPN839796A0/en
Priority claimed from AUPO2131A external-priority patent/AUPO213196A0/en
Priority claimed from AUPO3631A external-priority patent/AUPO363196A0/en
Application filed by Biota Scient Management filed Critical Biota Scient Management
Application granted granted Critical
Publication of ATE238552T1 publication Critical patent/ATE238552T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
AT97903154T 1996-03-01 1997-02-26 Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen ATE238552T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN8397A AUPN839796A0 (en) 1996-03-01 1996-03-01 Method and novel compounds for use therein
AUPO2131A AUPO213196A0 (en) 1996-09-04 1996-09-04 Method and novel compounds for use therein
AUPO3631A AUPO363196A0 (en) 1996-11-14 1996-11-14 Method and novel compounds for use therein
PCT/AU1997/000109 WO1997032214A1 (en) 1996-03-01 1997-02-26 Method of detection of influenza virus and compounds for use therein

Publications (1)

Publication Number Publication Date
ATE238552T1 true ATE238552T1 (de) 2003-05-15

Family

ID=27157905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903154T ATE238552T1 (de) 1996-03-01 1997-02-26 Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen

Country Status (13)

Country Link
US (2) US6242582B1 (enExample)
EP (1) EP0885391B1 (enExample)
JP (1) JP3753740B2 (enExample)
KR (1) KR19990087449A (enExample)
AT (1) ATE238552T1 (enExample)
CA (1) CA2245680C (enExample)
DE (1) DE69721242T2 (enExample)
ES (1) ES2197330T3 (enExample)
HU (1) HU223099B1 (enExample)
IL (1) IL125662A0 (enExample)
NO (1) NO326042B1 (enExample)
NZ (1) NZ331189A (enExample)
WO (1) WO1997032214A1 (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126357A (en) * 1996-04-02 2003-10-31 Bayer Ag Phenyl-substituted cyclic ketoenols, processes for their preparation and insecticide, acaricide and herbicide compositions containing them
JP3209946B2 (ja) 1996-07-22 2001-09-17 三共株式会社 ノイラミン酸誘導体
TR199901081T2 (xx) 1996-11-14 1999-08-23 Biota Scientific Management Pty.Ltd. Y�ntem ve bu y�ntemde kullan�lan yeni bile�imler.
CA2314431A1 (en) * 1997-12-18 1999-06-24 Sepracor Inc. Screening assays for the detection and diagnosis of influenza virus
JP3233392B2 (ja) 1998-01-22 2001-11-26 三共株式会社 ノイラミン酸誘導体を含有する抗インフルエンザ薬
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
AU1520300A (en) * 1998-11-05 2000-05-29 Biocryst Pharmaceuticals, Inc. New cyclopentane and cyclopentene compounds and use for detecting influenza virus
AUPP913999A0 (en) 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) * 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
JP4463553B2 (ja) * 2001-09-07 2010-05-19 バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド ノイラミニダーゼ阻害剤結合体の製造のための中間体
AUPR879701A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR879401A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
KR100942492B1 (ko) * 2001-11-09 2010-02-12 비오타 사이언티픽 매니지먼트 피티와이 엘티디 이량체 화합물 및 항바이러스제로서의 그의 용도
AUPR879501A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR879601A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
ES2820430T3 (es) 2005-05-09 2021-04-21 Labrador Diagnostics Llc Sistemas de fluidos para centros de atención y usos de los mismos
US11287421B2 (en) 2006-03-24 2022-03-29 Labrador Diagnostics Llc Systems and methods of sample processing and fluid control in a fluidic system
US8741230B2 (en) 2006-03-24 2014-06-03 Theranos, Inc. Systems and methods of sample processing and fluid control in a fluidic system
US8007999B2 (en) 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
EP2043767B1 (en) 2006-07-14 2020-03-25 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US20080113391A1 (en) * 2006-11-14 2008-05-15 Ian Gibbons Detection and quantification of analytes in bodily fluids
GB0702183D0 (en) * 2007-02-05 2007-03-14 Iti Scotland Ltd Pathogen binding
TWI546306B (zh) * 2007-04-11 2016-08-21 第一三共股份有限公司 神經胺酸衍生物之製造方法
US8158430B1 (en) 2007-08-06 2012-04-17 Theranos, Inc. Systems and methods of fluidic sample processing
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
CA2976814C (en) 2007-08-27 2022-12-13 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods for treating influenza
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
AU2008343745B2 (en) 2007-10-01 2012-05-10 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
DK2318832T3 (da) 2008-07-15 2014-01-20 Academia Sinica Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder
SG10201502531SA (en) 2009-10-19 2015-05-28 Theranos Inc Integrated Health Data Capture And Analysis System
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10338069B2 (en) 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
CN103068378B (zh) 2010-05-10 2016-07-06 中央研究院 具有抗流感活性的扎那米韦膦酸酯同类物及其制备方法
CN104203272A (zh) 2012-01-26 2014-12-10 长角牛疫苗和诊断有限责任公司 复合抗原序列及疫苗
AU2013306098A1 (en) 2012-08-18 2015-02-12 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
EP2905615B1 (en) * 2012-10-05 2018-11-28 Denka Seiken Co., Ltd. Method for measuring hemagglutinin from influenza virus
CN105682666B (zh) 2013-09-06 2021-06-01 中央研究院 使用醣脂激活人类iNKT细胞
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
IL249188B2 (en) 2014-05-27 2024-03-01 Academia Sinica Anti-her2 glycoantibodies and uses thereof
CZ2014527A3 (cs) * 2014-08-05 2016-02-17 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Způsob detekce aktivní formy analytů ve vzorku a stanovení schopnosti dalších látek vázat se do aktivních míst těchto analytů
CA2985652C (en) 2015-05-14 2020-03-10 Gerald W. FISHER Rapid methods for the extraction of nucleic acids from biological samples
WO2017156192A1 (en) 2016-03-08 2017-09-14 Academia Sinica Methods for modular synthesis of n-glycans and arrays thereof
CN108003065B (zh) * 2016-10-27 2021-01-08 中国石油化工股份有限公司 一种具有增稠作用的化合物和润滑脂以及它们的制备方法
KR102752322B1 (ko) 2023-09-20 2025-01-09 거제대학교산학협력단 단열 기능을 가진 립스틱 용기

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450877A1 (fr) * 1979-03-06 1980-10-03 Inst Nat Sante Rech Med Nouveaux tests par agglutination pour la detection des virus de la grippe, et reactifs pour la realisation de ces tests
CA2072368C (en) 1989-12-29 1998-06-30 Gregory A. Turner Methods for diagnosing human influenza and 4-position modified chromogenic n-acetylneuraminic acid substrates for use therein
AU7176091A (en) * 1989-12-29 1991-07-24 Symex Corp. Chromogenic 7- or 8-position modified n-acetylneuraminic acid substrates and methods for diagnosing human influenza therewith
WO1991009971A1 (en) 1990-01-05 1991-07-11 Symex Corp. Chromogenic 5-position modified neuraminic acid substrates and methods for diagnosing human influenza therewith
AU7150891A (en) 1990-01-10 1991-08-05 Symex Corp. Chromogenic 9-position modified n-acetylneuraminic acid substrates and methods for diagnosing human influenza therewith
SK282950B6 (sk) * 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
ATE182925T1 (de) 1990-12-31 1999-08-15 Oklahoma Med Res Found Verfahren zum visuellen nachweis der anwesenheit eines virus in einer klinischen probe
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
GB9516276D0 (en) 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
EP0881227A1 (en) * 1996-10-22 1998-12-02 Daikin Industries, Limited Gangliosides having fluorescent-tagged ceramide moieties

Also Published As

Publication number Publication date
EP0885391B1 (en) 2003-04-23
US6242582B1 (en) 2001-06-05
DE69721242T2 (de) 2004-01-29
NZ331189A (en) 1999-06-29
NO984004L (no) 1998-11-02
DE69721242D1 (de) 2003-05-28
NO326042B1 (no) 2008-09-08
US20020055094A1 (en) 2002-05-09
IL125662A0 (en) 1999-04-11
HUP9901679A2 (hu) 1999-09-28
HU223099B1 (hu) 2004-03-29
EP0885391A1 (en) 1998-12-23
EP0885391A4 (en) 2001-07-25
WO1997032214A1 (en) 1997-09-04
JP2000506008A (ja) 2000-05-23
HUP9901679A3 (en) 2000-06-28
JP3753740B2 (ja) 2006-03-08
CA2245680C (en) 2005-09-27
KR19990087449A (ko) 1999-12-27
NO984004D0 (no) 1998-08-31
ES2197330T3 (es) 2004-01-01
CA2245680A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
ATE238552T1 (de) Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen
LTPA2018513I1 (lt) Pakeistieji ciklopentano ir ciklopenteno junginiai, tinkami panaudoti kaip neuraminidazės inhibitoriai
AP9901531A0 (en) Method and novel compounds for use therein.
DE69842134D1 (de) Elektronische verfahren und vorrichtung zum nachweis von analyten
BR0009721A (pt) Inibidores de tirosina quinase de proteìna cìclica
EP1575414A4 (en) METHODS AND DEVICES FOR DETECTION AND THERAPY OF ATHEROMOUS PLAQUES
ATE360884T1 (de) Vorrichtung zum behandeln eines scheibenförmigen gegenstandes
DE60334664D1 (de) System und Verfahren zum Nachweis von biologischem und chemischem Material
GB0218993D0 (en) Method of,and system for,heuistically detecting viruses in executable code
ATE305453T1 (de) Selektive inhibitoren viraler oder bakterieller neuraminidase
DE60041761D1 (de) Tribonektine
CY1106992T1 (el) Καχαλαλιδη f και συναφεις ενωσεις
ATE404587T1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
DK0817622T3 (da) Transdermalt applicerbart lægemiddel med ACE-hæmmere
DE60137346D1 (de) Rechnerverfahren und -system zum ausführen von java-rechnerprogrammen
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
DE60208071D1 (de) Verfahren und system zur dynamischen kompilierung von bytecode nach maschinencode
DE50115254D1 (de) Verfahren zum erkennen und/oder begrenzen von kurzndler
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
NO20024755D0 (no) Metode
PT1019032E (pt) Processo para evitar a ma utilizacao de um sistema terapeutico transdermico
ATE255594T1 (de) Hepatitis b inhibitoren
ATE498692T1 (de) Verfahren zur bestimmung der aktivität von ornithine decarboxylase und zum identifizieren von effektoren der ornithine decarboxylase aktivität
DE602005016697D1 (de) Molekulardiagnoseverfahren und behandlung von demenz mit lewy-körperchen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties